Metastatic non-small-cell lung cancer: ESMO clinical practice guidelines

Primary lung cancer is the most common malignancy after non-melanocytic skin cancer, and the leading cause of human cancer deaths worldwide. This guidelines focuses on diagnosis, staging and risk assessment, treatment of stage IV NSCLC, treatment of oligometastatic NSCLC, and follow-up. Read more here.